Translating Molecular Biomarkers into Clinical Assays

Introduces new associations to established topics such as, quantitative proteomics in the context of immunhistochemistry (IHC) assays and tissue biobanking for personalized medicine Comprehensive review of traditional validation methods i.e. cell-based assays and mass spectrometry Defines the business and market of biomarkers through commercial biomarker assay kits and biomarker CRO services Includes supplementary material: sn.pub/extras